H van Tinteren Selected Research

H van Tinteren Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 07/2022 - 03/2000
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 01/2000
9	Neoplasms (Cancer) 07/2022 - 05/2000
3	Brain Neoplasms (Brain Tumor) 01/2020 - 05/2004
3	Disease Progression 05/2019 - 05/2004
3	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 08/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 09/2018
2	Stomach Neoplasms (Stomach Cancer) 01/2021 - 05/2019
2	Lung Neoplasms (Lung Cancer) 01/2020 - 06/2000
2	Neutropenia 12/2014 - 04/2000
2	Hand-Foot Syndrome 12/2014 - 03/2014
2	Rectal Neoplasms (Rectal Cancer) 10/2014 - 10/2004
2	Peritoneal Neoplasms 08/2014 - 06/2004
2	Exanthema (Rash) 03/2014 - 05/2004
2	Urinary Bladder Neoplasms (Bladder Cancer) 01/2012 - 03/2010
1	Peripheral Nervous System Diseases (PNS Diseases) 10/2018
1	Melanoma (Melanoma, Malignant) 03/2015
1	Carcinoma (Carcinomatosis) 10/2014
1	Stomatitis 03/2014
1	Fatigue 03/2014
1	Frailty 02/2014
1	Transitional Cell Carcinoma 03/2010
1	Non-Muscle Invasive Bladder Neoplasms 03/2010
1	Lymphatic Metastasis 04/2006
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 03/2006
1	Hemorrhage 01/2006
1	Hypoxia (Hypoxemia) 02/2005
1	Wilms Tumor (Wilm's Tumor) 12/2004
1	Margins of Excision 10/2004
1	Diarrhea 05/2004
1	Neoplasm Metastasis (Metastasis) 02/2003
1	Iron Deficiencies 12/2001
1	Fistula 11/2000

Drug/Important Bio-Agent (IBA)

6	Bevacizumab (Avastin)FDA Link 01/2021 - 03/2011
5	Paclitaxel (Taxol)FDA LinkGeneric 09/2018 - 01/2000
5	Capecitabine (Xeloda)FDA Link 09/2017 - 03/2014
3	Tamoxifen FDA LinkGeneric 07/2022 - 02/2002
3	PlatinumIBA 01/2021 - 03/2006
3	AnthracyclinesIBA 10/2018 - 11/2006
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2018 - 05/2002
3	Fluorouracil (Carac)FDA LinkGeneric 10/2014 - 05/2002
2	Estrogen ReceptorsIBA 07/2022 - 05/2000
2	Docetaxel (Taxotere)FDA Link 10/2018 - 04/2000
2	Indicators and Reagents (Reagents)IBA 02/2014 - 02/2002
2	Alkylating AgentsIBA 07/2011 - 04/2006
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2011 - 01/2010
2	Deoxyglucose (2 Deoxy D glucose)IBA 03/2011 - 02/2003
2	Gefitinib (Iressa)FDA Link 01/2010 - 05/2004
2	Epirubicin (Ellence)FDA LinkGeneric 04/2006 - 05/2002
2	Carboplatin (JM8)FDA LinkGeneric 04/2006 - 03/2006
2	Cyclin D1IBA 02/2002 - 05/2000
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021
1	Taxoids (Taxanes)IBA 10/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2018
1	N,N- dimethyl- N- hexadecyl- 1- octadecylammonium (DDAC)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2017
1	dabrafenibIBA 03/2015
1	tributyl phosphate (TBP)IBA 03/2015
1	VemurafenibIBA 03/2015
1	1-dodecylpyridoxal (PLD)IBA 03/2014
1	liposomal doxorubicin (Doxil)FDA Link 03/2014
1	CP 4126IBA 08/2013
1	DNA (Deoxyribonucleic Acid)IBA 07/2011
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 07/2011
1	FluorineIBA 03/2011
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Tyrosine Kinase InhibitorsIBA 01/2010
1	Carcinoembryonic AntigenIBA 01/2010
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 11/2006
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 04/2006
1	Etoposide (VP 16)FDA LinkGeneric 03/2006
1	Hypoxia-Inducible Factor 1IBA 02/2005
1	Transcription Factors (Transcription Factor)IBA 02/2005
1	N 30IBA 12/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 12/2002
1	LigandsIBA 02/2002
1	Cyclin AIBA 02/2002
1	Ferritins (Ferritin)IBA 12/2001
1	16-iodo-3-methylhexadecanoic acid (MIHA)IBA 08/2001

Therapy/Procedure

16	Drug Therapy (Chemotherapy) 07/2022 - 01/2000
4	Radiotherapy 04/2006 - 05/2004
3	Therapeutics 01/2021 - 01/2010
3	Adjuvant Chemotherapy 01/2021 - 11/2006
3	Neoadjuvant Therapy 08/2014 - 05/2002
2	Cranial Irradiation 01/2020 - 10/2019
2	Hyperthermic Intraperitoneal Chemotherapy 05/2019 - 06/2004
2	Cystectomy 01/2012 - 03/2010
2	Induction Chemotherapy 02/2003 - 05/2002
1	Immunotherapy 01/2020
1	Gastrectomy 05/2019
1	Laparotomy 05/2019
1	Cytoreduction Surgical Procedures 05/2019
1	Chemoradiotherapy 10/2014
1	Urinary Diversion (Ileal Conduit) 01/2012
1	Aftercare (After-Treatment) 03/2010
1	Surgical Amputation (Amputations) 08/2006
1	Tracheotomy 01/2006
1	Adjuvant Radiotherapy 10/2004
1	Prostheses and Implants (Prosthesis) 11/2000